Akari Therapeutics (AKTX) Enterprise Value Growth (3y) (2014 - 2025)

Akari Therapeutics (AKTX) Enterprise Value Growth (3y) (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn -
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn
9 Abivax 90.15 Bn 90.15 Bn -
10 Regeneron Pharmaceuticals 63.59 Bn 54.83 Bn 3.31 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 26.77%
Dec 31, 2024 34.27%
Dec 31, 2022 -32.22%
Dec 31, 2021 -19.79%
Dec 31, 2019 49.35%
Mar 31, 2019 53.58%
Dec 31, 2018 57.09%
Dec 31, 2017 -103.66%
Dec 31, 2016 -330.33%
Dec 31, 2015 -296.70%
Dec 31, 2014 -721.59%